Inventor · disambiguated record
George T. Topalov
Also filed as: TOPALOV GEORGE · TOPALOV GEORGE T
31 granted patents·8 pending applications·151 citations·filing 2003–2025
96Inventor score
Files withARRAY BIOPHARMA INC13KNOPP BIOSCIENCES LLC11BIOHAVEN THERAPEUTICS LTD4SIONNA THERAPEUTICS INC3ALLEN SHELLEY2
Top patents by PatentIndex Score
39 records- 0196US11724990B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2022·Granted Aug 15, 2023·4 cites·14 claims
- 0296US11261162B2KV7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2020·Granted Mar 1, 2022·3 cites·20 claims
- 0395US10851067B2Kv7 channel activators compositions and methods of useKNOPP BIOSCIENCES LLC·Filed 2019·Granted Dec 1, 2020·6 cites·28 claims
- 0495US9481653B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2015·Granted Nov 1, 2016·15 cites·19 claims
- 0595US7777032B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Aug 17, 2010·11 cites·2 claims
- 0695US7585975B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Sep 8, 2009·11 cites·16 claims
- 0793US9914708B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Mar 13, 2018·10 cites·16 claims
- 0892US10385025B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Aug 20, 2019·9 cites·16 claims
- 0992US10106536B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2017·Granted Oct 23, 2018·5 cites·12 claims
- 1091US9650376B2Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2014·Granted May 16, 2017·8 cites·23 claims
- 1190US9676791B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2012·Granted Jun 13, 2017·5 cites·9 claims
- 1290US7491829B2RAF inhibitor compounds and methodsARRAY BIOPHARMA INC·Filed 2006·Granted Feb 17, 2009·17 cites·49 claims
- 1389US7501427B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2003·Granted Mar 10, 2009·14 cites·37 claims
- 1488US12351559B2Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Jul 8, 2025·0 cites·16 claims
- 1584US10906877B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2019·Granted Feb 2, 2021·1 cites·8 claims
- 1684US10221194B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Mar 5, 2019·2 cites·1 claims
- 1783US12286408B2KV7 channel activators compositions and methods of useBIOHAVEN THERAPEUTICS LTD·Filed 2023·Granted Apr 29, 2025·0 cites·16 claims
- 1882US8278314B2Quinazoline analogs as receptor tyrosine kinase inhibitorsWALLACE ELI·Filed 2008·Granted Oct 2, 2012·6 cites·14 claims
- 1981US7452895B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2004·Granted Nov 18, 2008·14 cites·17 claims
- 2077US8138181B2Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitorsALLEN SHELLEY·Filed 2008·Granted Mar 20, 2012·3 cites·29 claims
- 2177US2021269455A1Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2275US11834418B2Benzoimidazol-1,2-yl amides as Kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2020·Granted Dec 5, 2023·0 cites·20 claims
- 2375US9174981B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsBOYS MARK LAURENCE·Filed 2011·Granted Nov 3, 2015·3 cites·30 claims
- 2474US11174273B2Quinazoline analogs as receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Nov 16, 2021·0 cites·2 claims
- 2572US9809590B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Nov 7, 2017·1 cites·29 claims
- 2671US8575145B2Triazolopyridine compounds as PIM kinase inhibitorsALLEN SHELLEY·Filed 2009·Granted Nov 5, 2013·2 cites·29 claims
- 2768US10526328B2Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activatorsKNOPP BIOSCIENCES LLC·Filed 2018·Granted Jan 7, 2020·0 cites·1 claims
- 2868US2025197422A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2967US10669269B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 3062US8841455B2Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitorsBOYS MARK LAURENCE·Filed 2010·Granted Sep 23, 2014·1 cites·41 claims
- 3161US2025066351A1Pyrazolo[1,5-a]pyridin-2,3-yl amides as kv7 channel activatorsBIOHAVEN THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 3257US2009176809A1Raf inhibitor compounds and methodsLAIRD ELLEN·Filed 2008·Application pending·0 cites
- 3349US2025248975A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3449US2025197420A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3548US2010144751A1IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORSARRAY BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 3644US8987251B2Triazolopyridine compounds as PIM kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Mar 24, 2015·0 cites·33 claims
- 3743US7566716B2Imidazopyrazines as Raf inhibitor compoundsARRAY BIOPHARMA INC·Filed 2006·Granted Jul 28, 2009·0 cites·21 claims
- 3840US2020062714A1BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORSKNOPP BIOSCIENCES LLC·Filed 2017·Application pending·0 cites
- 3936US8865726B2Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsANDREWS STEVEN W·Filed 2010·Granted Oct 21, 2014·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when George T. Topalov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →